featured
Ipilimumab for Patients With Relapse After Allogeneic Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ipilimumab for Patients With Relapse After Allogeneic Transplantation
N. Engl. J. Med 2016 Jul 14;375(2)143-153, MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, AP Lukez, D Avigan, YB Chen, P McSweeney, NR LeBoeuf, MS Rooney, M Bowden, CW Zhou, SR Granter, JL Hornick, SJ Rodig, M Hirakawa, M Severgnini, FS Hodi, CJ Wu, VT Ho, C Cutler, J Koreth, EP Alyea, JH Antin, P Armand, H Streicher, ED Ball, J Ritz, A Bashey, RJ SoifferFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.